Baseline characteristics of participants. by Hyungjong Park (10147327)

“…RHF was defined as having an eGFR > 120 mL/min ∙ 1.73 m² defined by the eGFR range or being in the 10^th decile of whole eGFR level.…”

PRISMA flow diagram for selection of studies. by Haribalakrishna Balasubramanian (21865971)

“…The primary outcomes of interest were all-cause mortality and neurodevelopmental impairment at latest follow up. A total of 61 studies from 20 HICs were included. …”

Funnel plot for assessment of publication bias. by Haribalakrishna Balasubramanian (21865971)

“…The primary outcomes of interest were all-cause mortality and neurodevelopmental impairment at latest follow up. A total of 61 studies from 20 HICs were included. …”

Sensitivity analysis. by Haribalakrishna Balasubramanian (21865971)

“…The primary outcomes of interest were all-cause mortality and neurodevelopmental impairment at latest follow up. A total of 61 studies from 20 HICs were included. …”

Certainty of Evidence. by Haribalakrishna Balasubramanian (21865971)

“…The primary outcomes of interest were all-cause mortality and neurodevelopmental impairment at latest follow up. A total of 61 studies from 20 HICs were included. …”

Characteristics of included studies. by Haribalakrishna Balasubramanian (21865971)

“…The primary outcomes of interest were all-cause mortality and neurodevelopmental impairment at latest follow up. A total of 61 studies from 20 HICs were included. …”

Risk of bias assessment. by Haribalakrishna Balasubramanian (21865971)

“…The primary outcomes of interest were all-cause mortality and neurodevelopmental impairment at latest follow up. A total of 61 studies from 20 HICs were included. …”

Virucidal activity of vaginal acids against HSV-2 and HPV-16. by Muriel Aldunate (22411177)

LA is a more potent inhibitor of HIV-1 virion-associated RT activity compared to acetic acid or low pH (HCl) alone. by Muriel Aldunate (22411177)

Virucidal activity of equimolar levels of the protonated form of vaginal LA, SCFAs, and succinic acid. by Muriel Aldunate (22411177)

Analysis of L-LA on gp120 protein conformation and rCD4 binding. by Muriel Aldunate (22411177)

Degradation of virion-associated RNA following acid treatment. by Muriel Aldunate (22411177)

LA has minimal impact on HIV-1 virion integrity and surface levels of gp120 envelope protein. by Muriel Aldunate (22411177)

Virucidal activity of LA, SCFA, and succinic acid combinations associated with an optimal vaginal microbiota or BV, representing a non-optimal vaginal microbiota. by Muriel Aldunate (22411177)

The relationship between HBV antigens deposition in kidneys and renal prognosis in IgA nephropathy patients infected with HBV by Yun Guo (135103)

“…The primary outcome was a composite of 30% decrease in eGFR from the baseline, kidney failure and all-cause mortality. …”

PRISMA flow chart. by Wanda Forczek-Karkosz (12231668)

“…Research results in both static and dynamic conditions are inconclusive, showing either a decrease, no change, or improvement in postural equilibrium as pregnancy advances. …”

Demographics of the enrolled patients. by Yuka Kasai (21354922)

“…</p><p>Results</p><p>Eighty-eight patients were included (51 men and 37 women, mean age: 67.3 ± 13.4 years). The success rate in the seated position without the eye drop aid was 71.6%, and this rate decreased with increasing age; with the eye drop aid, the success rate improved significantly to 97.8%. …”

Overhead view of the eye drop aid. by Yuka Kasai (21354922)

“…</p><p>Results</p><p>Eighty-eight patients were included (51 men and 37 women, mean age: 67.3 ± 13.4 years). The success rate in the seated position without the eye drop aid was 71.6%, and this rate decreased with increasing age; with the eye drop aid, the success rate improved significantly to 97.8%. …”

Key safety measures including adverse events. by Anuja Dokras (8679261)

“…As there is a lack of robust evidence on the impact of these first-line medications on cardiovascular disease (CVD) risk, we compared the effect of COCPs, metformin or both on prevalence of metabolic syndrome (MetS) in participants with hyperandrogenic PCOS and hypothesized that COCPs would increase prevalence of MetS while metformin would decrease prevalence of MetS.</p><p>Methods and findings</p><p>We conducted a multicenter, double-blind, double-dummy, randomized trial (COMET-PCOS) in participants between ages ≥18 and ≤40 years and body mass index (BMI) ≥25 kg/m² and ≤ 48 kg/m² with hyperandrogenic PCOS (defined by the Rotterdam criteria). …”

Percent change in production and consumption sustainability for the top 25 seafood producing countries (according to FAO data). by Kayla M. Blincow (20370884)